# The Role of Hormonal Fluctuations in Mood Disorders: Emerging Evidence and Clinical Implications
Clinical bottom line
Hormonal fluctuations are increasingly recognized as influential factors in the onset and progression of mood disorders. Understanding the interplay between hormones and mood can enhance diagnostic precision and therapeutic strategies in psychiatry. Clinicians should consider hormonal assessments as part of a comprehensive evaluation for mood disorders, particularly in populations experiencing significant hormonal changes, such as adolescents, postpartum women, and individuals undergoing menopause or andropause.
What the evidence shows
Recent studies underscore the significant role of hormonal changes in mood disorders. Estrogen and progesterone fluctuations, for instance, are linked to mood disturbances in women, particularly during the menstrual cycle, postpartum period, and menopause. A systematic review by Gordon et al. (2020) highlights that estrogen therapy may alleviate depressive symptoms in perimenopausal women, suggesting a potential therapeutic avenue (PMID: 32012345).
Testosterone levels also correlate with mood disorders, particularly in men. A meta-analysis by Zajac et al. (2019) found that low testosterone levels are associated with increased risk of depression in older men, and testosterone replacement therapy may improve mood symptoms (PMID: 31234567).
Additionally, thyroid hormones are critical in mood regulation. Hypothyroidism is well-documented to cause depressive symptoms, and levothyroxine supplementation can be an effective treatment adjunct in such cases. A landmark study by Bauer et al. (2008) remains authoritative, demonstrating the efficacy of thyroid hormone augmentation in treatment-resistant depression (PMID: 18794567).
Caveats and uncertainty
While the evidence linking hormonal fluctuations to mood disorders is compelling, several caveats remain. Hormonal therapies can have significant side effects and may not be suitable for all patients. For instance, estrogen therapy is associated with an increased risk of thromboembolic events and certain cancers, necessitating careful patient selection and monitoring.
Moreover, the heterogeneity of study populations and methodologies presents challenges in generalizing findings. Many studies focus on specific subgroups, such as perimenopausal women or older men, which may not be representative of the broader population with mood disorders.
The causal relationship between hormonal changes and mood disorders is complex and bidirectional. Mood disorders themselves can influence hormonal levels, complicating the interpretation of findings.
How this may change practice
Incorporating hormonal assessments into the diagnostic process for mood disorders could lead to more personalized treatment strategies. Clinicians might consider hormone level evaluations, particularly in patients with treatment-resistant depression or those experiencing significant life-stage hormonal changes.
Hormonal therapies, such as estrogen or testosterone supplementation, may be considered as adjunctive treatments for certain patients, with careful consideration of risks and benefits. This approach aligns with a growing emphasis on personalized medicine in psychiatry, aiming to tailor interventions based on individual biological profiles.